← back to search

Michael L. Schilsky

Yale University · US
Area of research
Nutrition and Dietetics · Health, Toxicology and Mutagenesis
Research interest
Research interests include Trace Elements in Health, Heavy Metal Exposure and Toxicity, Iron Metabolism and Disorders, and Liver Disease and Transplantation.
h-index
57
citations
15,560
works
273
NIH funding
primary concept
Medicine
email

Recent publications

Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease.
2026cited by 0position: contributordoi
Wilson disease is a single gene disorder – comprehensive analysis of patients with prior negative genetic testing
JHEP Reports 2026cited by 0position: contributordoi
Clinical and Genetic Profile of Pediatric and Adult Wilson's Disease in India
Gastro Hep Advances 2025cited by 3position: contributordoi
Changes in the FXR-cistrome and alterations in bile acid physiology in Wilson disease.
2025cited by 1position: contributordoi
Reply to: “Oral bis-choline tetrathiomolybdate rapidly improves copper balance in patients with Wilson disease”
Journal of Hepatology 2025cited by 0position: contributordoi
Effects of tetrathiomolybdate on copper metabolism in healthy volunteers and in patients with Wilson disease
Journal of Hepatology 2024cited by 71position: contributordoi
Effects of trientine and penicillamine on intestinal copper uptake: A mechanistic 64 Cu PET/CT study in healthy humans.
2024cited by 13position: contributordoi
Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets
JHEP Reports 2024cited by 8position: contributordoi
An abbreviated history of liver transplantation.
2024cited by 0position: contributordoi
Association of FDA Mandate Limiting Acetaminophen (Paracetamol) in Prescription Combination Opioid Products and Subsequent Hospitalizations and Acute Liver Failure
JAMA 2023cited by 27position: middledoi
A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases
Hepatology 2022cited by 168position: firstdoi
A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases
Hepatology 2022cited by 104position: firstdoi
Connecting copper and cancer: from transition metal signalling to metalloplasia
Nature reviews. Cancer 2021cited by 1,247position: middledoi
American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease
Hepatology 2021cited by 155position: middledoi
Coagulopathy, Bleeding Events, and Outcome According to Rotational Thromboelastometry in Patients With Acute Liver Injury/Failure
Hepatology 2021cited by 49position: middledoi
Recent advances in Wilson disease.
2021cited by 31position: contributordoi
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement
Hepatology 2020cited by 477position: middledoi
Clinical and Neurologic Outcomes in Acetaminophen-Induced Acute Liver Failure: A 21-Year Multicenter Cohort Study
Clinical Gastroenterology and Hepatology 2020cited by 39position: middledoi
Clinical practice guidelines in Wilson disease.
2019cited by 44position: contributordoi
Transjugular intrahepatic portosystemic shunt as a bridge to liver transplant: Current state and future directions
Transplantation Reviews 2019cited by 19position: contributordoi
Wilson disease
Nature Reviews Disease Primers 2018cited by 872position: lastdoi
List of Contributors
Elsevier eBooks 2018cited by 0position: middledoi
Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study
˜The œLancet. Gastroenterology & hepatology 2017cited by 168position: lastdoi
The Natural History of Severe Acute Liver Injury
The American Journal of Gastroenterology 2017cited by 143position: middledoi
Outcomes in Adults With Acute Liver Failure Between 1998 and 2013
Annals of Internal Medicine 2016cited by 383position: middledoi
Acute liver injury and acute liver failure from mushroom poisoning in <scp>N</scp>orth <scp>A</scp>merica
Liver International 2016cited by 79position: middledoi
Association Between Plasma Level of Galectin-9 and Survival of Patients With Drug-Induced Acute Liver Failure
Clinical Gastroenterology and Hepatology 2015cited by 20position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 10 papers (2019–2026)Peter Ott · Aarhus University5 papers (2024–2026)Thomas D. Sandahl · University College South Denmark4 papers (2024–2026)Karl Heinz Weiss · Salem Hospital4 papers (2017–2022)Brendan M. McGuire · University of Alabama at Birmingham4 papers (2016–2021)Bilal Hameed · Yale University3 papers (2016–2021)Oren K. Fix · University of North Carolina at Chapel Hill3 papers (2016–2021)Jeff M. Bronstein · VA West Los Angeles Medical Center3 papers (2017–2022)K. Rajender Reddy · Fred Hutch Cancer Center3 papers (2020–2025)Robert J. Fontana · University of Edinburgh3 papers (2020–2021)William M. Lee · University of California, San Francisco2 papers (2016–2021)Péter Ferenci · Medical University of Vienna2 papers (2017–2018)Anna Członkowska · London School of Hygiene & Tropical Medicine2 papers (2017–2018)Svetlana Lutsenko · Oregon Health & Science University2 papers (2018–2021)M. Kay Washington · Vanderbilt University Medical Center2 papers (2022–2022)Mark W. Russo · Wake Forest University2 papers (2020–2021)Eve A. Roberts · Hospital for Sick Children2 papers (2022–2022)Aftab Ala · King's College - North Carolina2 papers (2024–2026)Rubens G. Cury · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo2 papers (2024–2026)Eugene Scott Swenson · Oberlin College2 papers (2024–2024)